Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism

Katsuhiko Okumura, Tomoko Kita, Shinji Chikazawa, Fusao Komada, Seigo Iwakawa, Yusuke Tanigawara

Research output: Contribution to journalArticlepeer-review

74 Citations (Scopus)


We studied the genotypes of polymorphic N-acetyltransferase (NAT2) in 145 Japanese subjects by the polymerase chain reaction-restriction fragment length polymorphism method. The rapid-type NAT2*4 was expressed at a higher frequency (68.6%) than the slow-type genes with specific point mutations (NAT2*6A, 19.3%; NAT2*7B, 9.7%; NAT2*5B, 2.4%). The frequency of NAT2* genotypes consisted of 44% of a homozygote of NAT2*4, 49% of a heterozygote of NAT2*4 and mutant genes, and 7% of a combination of mutant genes. The metabolic activity for procainamide to N-acetylprocainamide was measured in 11 healthy subjects whose genotype had been determined. Although the acetylation activity substantially varied interindividually, the variability was considerably reduced after classification according to the genotype. The N-acetylprocainamide/procainamide ratio in urinary excretion was 0.60 ± 0.17 (mean ± SD) for those with NAT2*4/*4, 0.37 α 0.06 for NAT2*4/*6A, 0.40 ± 0.03 for NAT2*4/*7B, and 0.17 for NAT2*6A/*7B. The results indicated that the NAT2* genotype correlates with acetylation of procainamide.

Original languageEnglish
Pages (from-to)509-517
Number of pages9
JournalClinical Pharmacology and Therapeutics
Issue number5
Publication statusPublished - 1997 May 1
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism'. Together they form a unique fingerprint.

Cite this